Dr. Alland is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
150 Bergen St
Newark, NJ 07103Phone+1 973-972-2179Fax+1 973-972-6804
Education & Training
- Montefiore Medical Center/Albert Einstein College of Medicine (Moses and Weiler Campuses)Fellowship, Infectious Disease, 1988 - 1992
- New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1984 - 1987
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1984
Certifications & Licensure
- NJ State Medical License 2001 - 2025
- VA State Medical License 2017 - 2020
- FL State Medical License 2017 - 2019
- TX State Medical License 2017 - 2018
- NY State Medical License 1986 - 2003
- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 187 citationsThiolactomycin and related analogues as novel anti-mycobacterial agents targeting KasA and KasB condensing enzymes in Mycobacterium tuberculosis.Laurent Kremer, James D. Douglas, Alain R. Baulard, Caroline B. Morehouse, Mark R. Guy
The Journal of Biological Chemistry. 2000-06-02 - 147 citationsOverexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosisMichelle H. Larsen, Catherine Vilchèze, Laurent Kremer, Gurdyal S. Besra, Linda M. Parsons
Molecular Microbiology. 2002-10-01 - 660 citationsA detailed analysis of 16S ribosomal RNA gene segments for the diagnosis of pathogenic bacteria.Soumitesh Chakravorty, Danica Helb, Michele Burday, Nancy D. Connell, David Alland
Journal of Microbiological Methods. 2007-05-01
Journal Articles
- Bacterial Factors That Predict Relapse After Tuberculosis TherapyDavid Alland, MD, The New England Journal of Medicine
- Bacterial Factors That Predict Relapse After Tuberculosis TherapyDavid Alland, W Henry Boom, The New England Journal of Medicine
Press Mentions
- Pfizer, Moderna Shots Safe During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVIDJanuary 27th, 2022
- This New Testing Kit Can Detect Any COVID-19 Variant in MinutesJanuary 27th, 2022
- Pfizer, Moderna Draws Safely During in Vitro Fertilization; Healthy Gut Bacteria May Help Prevent Long COVIDJanuary 26th, 2022
- Join now to see all
Grant Support
- On Demand Blood Tests For Select Agent DiagnosisNational Institute Of Allergy And Infectious Diseases2012
- Development Of A Second Generation Mdr-Xdr TB AssayNational Institute Of Allergy And Infectious Diseases2009–2012
- Rapid Diagnosis Of XDR TuberculosisNational Institute Of Allergy And Infectious Diseases2009–2011
- Development Of A Molecular Blood CultureNational Institute Of Allergy And Infectious Diseases2009–2010
- Afb Smears For Drug Resistance Detection And Surveillance In MTB.National Institute Of Allergy And Infectious Diseases2009–2010
- Integrated Dual-Use Systems For Bio-Defense &Sepsis DiagnosisNational Institute Of Allergy And Infectious Diseases2007–2010
- Sample Processing Cartridges For Rapid PCR TB DetectionNational Institute Of Allergy And Infectious Diseases2006–2008
- Detection Of Select Agents In Single-Well AssaysNational Institute Of Allergy And Infectious Diseases2003–2007
- Towards Drugs That Prevent Resistance To The HIV Oi, TBNational Institute Of Allergy And Infectious Diseases2005–2006
- Tuberculosis Genotyping And Evolutionary ConsortiumNational Institute Of Allergy And Infectious Diseases2002–2005
- Population Based Investigations Of TuberculosisNational Institute Of Allergy And Infectious Diseases2001–2004
- Sample Processing Cartridges For Rapid PCR TB DetectionNational Institute Of Allergy And Infectious Diseases2002
- Population Based Investigations Of TuberculosisNational Institute Of Allergy And Infectious Diseases2000–2001
- Tuberculosis Curriculum For An Urban Medical CenterNational Heart, Lung, And Blood Institute1997–2000
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: